Lung cancer
Conditions
Interventions
Group 1:serratus anterior plane block with ropivacaine combined with hydromorphone
Group 3:saline serratus plane block
Sponsors
Shaoxing Shangyu People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients undergoing thoracoscopic lung surgery; 2. ASA classification I-II; 3. Aged >18 years, body mass index (BMI) 18-28 kg/m^2.
Exclusion criteria
Exclusion criteria: 1. Those who refuse postoperative analgesia; 2. Those who are allergic to experimental drugs, have a history of acute or chronic pain, have been taking analgesics or alcoholism for a long time, and have recently used opioids; 3. Patients with coagulation dysfunction, recent application of anticoagulants, or infection at the puncture site; 4. Patients with severe heart, liver, kidney and other important organ dysfunction; 5. Those with active peptic ulcer or bleeding; 6. Intraoperative conversion to thoracotomy; 7. Patients with speech communication impairment, cognitive impairment and mental illness; 8. Patients are reluctant to participate in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analogue scale score;IL-10;TNFa; | — |
Secondary
| Measure | Time frame |
|---|---|
| PCIA compressions in 48 hours;The occurrence of adverse reactions; | — |
Countries
China
Contacts
Public ContactChen Xuefeng
Outcome results
None listed